Not a good buy right now for an impatient buyer: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and momentum is not confirming a reversal.
Insider activity is a major red flag (insiders selling sharply), which typically caps near-term upside.
Options positioning is call-heavy, but there is essentially no option trading volume today—sentiment signal is weak/illiquid rather than conviction.
With no fresh news catalysts and only modestly improving (but still negative) earnings, the risk/reward does not favor buying at current levels (~14.8).
Technical Analysis
Pre-market price ~14.83; key pivot at 14.71: price is only slightly above pivot, implying limited immediate edge.
Trend: Bearish structure with moving averages stacked negatively (SMA_200 > SMA_20 > SMA_5), suggesting the broader downtrend remains intact.
MACD: Histogram at -0.0139 (below zero) and negatively contracting—bearish momentum is easing, but no bullish crossover/confirmation yet.
RSI(6) ~53.95: neutral; not oversold, so there’s no “forced bounce” setup.
Levels: Support S1 14.43 then S2 14.25; Resistance R1 14.99 then R2 15.17. A clean break and hold above ~15.00 would be needed to justify a more confident long.
Pattern-based odds provided: ~50% chance of -0.69% next day, +0.51% next week, -1.08% next month—skews slightly negative over the near-term horizon.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Open interest put/call ratio 0.08 (puts very low vs calls): positioning appears optimistic.
However, today’s options volume is 0 (calls 0, puts 0): the put/call signal is not being reinforced by active trading.
Implied vol (30D) 51.58 vs historical vol 19.12: options are pricing elevated uncertainty; with a small/illiquid name, this can reflect risk premium more than bullish opportunity.
IV percentile 56.57 (mid-range): not extremely high relative to its own history, but still elevated versus realized volatility.
Technical Summary
Sell
5
Buy
5
Positive Catalysts
Hedge funds: neutral (no notable negative positioning trend flagged).
Neutral/Negative Catalysts
Option market is effectively inactive today (0 volume), reducing confidence in sentiment read-through and limiting tactical opportunity.
Gross margin: 53.58%, down 1.03% YoY (some margin compression).
Summary: fundamentals show mild improvement (loss narrowing) but not strong growth; not the kind of momentum that typically supports an “urgent buy now” decision.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2025-11-18: Citizens JMP kept Outperform but cut price target from $24 to $20 after Q3.
Trend takeaway: rating stayed positive, but the target reduction signals tempered near-term expectations.
Wall Street pros: positive long-term framing (fundamentals next year; potential value creation via refinancing / capital access).
Wall Street cons: the cut in target suggests execution and/or macro/REIT headwinds are still meaningful; near-term upside conviction appears moderated.
Politicians/congress: no recent congress trading data available; no politician activity provided.
Wall Street analysts forecast BRT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRT is 18 USD with a low forecast of 16 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BRT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRT is 18 USD with a low forecast of 16 USD and a high forecast of 20 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 14.830
Low
16
Averages
18
High
20
Current: 14.830
Low
16
Averages
18
High
20
Citizens JMP
Outperform
downgrade
$24 -> $20
AI Analysis
2025-11-18
Reason
Citizens JMP
Price Target
$24 -> $20
AI Analysis
2025-11-18
downgrade
Outperform
Reason
Citizens JMP lowered the firm's price target on BRT Apartments to $20 from $24 and keeps an Outperform rating on the shares following the Q3 print. The firm expects fundamentals to provide a favorable backdrop next year, and thinks additional capital could be accessed through debt refinancing in the future to unlock opportunities for value creation, the analyst tells investors in a research note.
B. Riley
Buy
maintain
$21
2025-10-01
Reason
B. Riley
Price Target
$21
2025-10-01
maintain
Buy
Reason
B. Riley raised the firm's price target on BRT Apartments to $21 from $19.50 and keeps a Buy rating on the shares. The firm sees the company benefitting from the lower interest rate environment. BRT offers \"compelling value\" at current share levels despite its small cap size and limited trading volume, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BRT
